Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Continued Examination Under 37 CFR 1.114
A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on November 19, 2025, has been entered.
Status of Claims
Claims 1-20 were previously pending and subject to a Final Office Action having a notification date of May 19, 2025 (“Final Office Action”). Following the Final Office Action, Applicant filed the RCE and an amendment on November 19, 2025 (“Amendment”), amending claims 1, 2, 14-16, and 20.
The present non-final Office Action addresses pending claims 1-20 in the Amendment.
Response to Arguments
Response to Applicant’s Arguments Regarding Claim Rejections Under 35 USC §103
These rejections are withdrawn in view of the Amendment.
Claim Rejections - 35 USC § 112
The following is a quotation of the first paragraph of 35 U.S.C. 112(a):
(a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention.
The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112:
The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention.
Claims 1-20 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention.
Each of independent claims 1, 14, and 20 has been amended to recite "wherein each first interactable digital block is associated with a first degree of certainty of the potential relationship determined by an artificial intelligence system," "presenting with each first interactable digital block the first degree of certainty of the potential relationship, wherein the first degree of certainty is updated in real-time as the individual search criteria changes," and "wherein each second interactable digital block is presented with a second degree of certainty of the potential relationship." While [0050] and steps 1012 and 1014 of Figure 10 of the present specification discuss/illustrate how a "degree of certainty" between individual search criteria and known diseases/health conditions can be determined and how the potential relationships and related findings can be provided through a visualization interface, neither these portions nor any other portions of the present specification appears to disclose each of the first and second interactable digital blocks to be associated/presented with such degrees of certainty, much less where the first degree of certainty is updated in real-time as the individual search criteria changes, all as recited in independent claims 1, 14, and 20.
The remaining claims are rejected based on their dependency from claims 1, 14, or 20.
Conclusion
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. The references on the attached PTO-892 disclose various manners of using AI and ML-learning techniques to calculate probabilities/likelihoods/confidence/certainties of medical diseases/conditions of patients based on various types of patient inputs such as demographic, physiological, symptom, and genetic data.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to JONATHON A. SZUMNY whose telephone number is (303) 297-4376. The examiner can normally be reached Monday-Friday 7-5.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jason Dunham, can be reached on 571-272-8109. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/JONATHON A. SZUMNY/Primary Examiner, Art Unit 3686